Buscar en
Annals of Hepatology
Toda la web
Inicio Annals of Hepatology The role of small heterodimer partner in hepatic lipid homeostasis
Journal Information
Vol. 14. Issue 2.
Pages 286-287 (March - April 2015)
Share
Share
Download PDF
More article options
Vol. 14. Issue 2.
Pages 286-287 (March - April 2015)
Open Access
The role of small heterodimer partner in hepatic lipid homeostasis
Visits
1053
Beatriz Barranco-Fragoso*, Paloma Almeda-Valdes**, Nancy Aguilar-Olivos***, Nahum Méndez-Sánchez***,
Corresponding author
nmendez@medicasur.org.mx

Correspondence and reprint request:
* Department of Gastroenterology, National Medical Center “20 Noviembre”. Mexico City. Mexico
** Department of Endocrinology and Metabolism, Instituto Nacional de Ciencias Medicas y Nutrición Salvador Zubirán, Mexico City, Mexico
*** Liver Research Unit, Medica Sur Clinic & Foundation. Mexico City, Mexico
This item has received

Under a Creative Commons license
Article information
Full Text
Bibliography
Download PDF
Statistics
Full Text
Article commented:

Lee SM, Zhang Y, Tsuchiya H, Smalling R, Jet-ten AM, Wang L. Small heterodimer partner/neuronal PAS domain protein 2 axis regulates the oscillation of liver lipid metabolism. Hepatology 2015; 6: 497-505.

Comment:

Small heterodimer partner (SHP, NR0B2) interacts with orphan members of the nuclear receptor superfamily, including the constitutive androstane receptor, retinoid receptors, thyroid hormone receptor, and orphan receptor MB67.1 The SHP ability to bind directly to a variety of nuclear receptors is crucial for its physiological function as a transcriptional inhibitor of gene expression. SHP binds to the ligand-dependent transactivation domain AF-2 through two functional LXXLL-related motifs which are located in the putative N-terminal helix 1 of the ligand-binding domain LBD and in the helix of the C-terminal region.2 SHP gene is expressed and detected in a variety of tissues in mice and human.3,4 For example, in some strain of mice (12931/SvJ and C57/BL6) as well as in humans SHP is predominantly expressed in the gallbladder and liver.3,4

Interestingly, it has been reported that a variety of nuclear receptors and transcription factors target the SHP promoter and regulate SHP gene expression, including those involved in the lipid metabolism and the core circadian component CLOCK-BMAL1.5

In the present study Lee, et al. explored the potential role of SHP to coordinate the metabolism and circadian rhythms. The investigators studied Shp+/+ and Shp-/- mice on a C57BL/6 background (n = 3-5/group) which were fed a standard chow diet and water ad libitum. Serum and livers were collected at Zeitgeber time 2, 6, 10, 14, 18 and 22. In vivo and in vitro assays included RNA sequencing, quantitative polymerase chain reaction, very-low density lipoprotein production, adenovirus overexpression and small interfering RNA knockdown, serum parameters, circadian locomotor activity, Oil Red O staining, transient transfection, luciferase reporter assay, chromatin immunoprecipitation assay, gelshift assay, coimmunoprecipitation, and western blottings. The researchers observed that Shp deficiency had a robust global impact on major liver metabolic genes. Several components of the liver clock, including peroxisome proliferator-activated receptor-γ, coactivator 1 (Pgc-1α), neuronal PAS domain-containing protein 2 (Npas2), and retinoic acid-related orphan receptor (Ror)α/γ were sharply induced in Shp-/- liver. At the molecular level, SHP inhibited Npas2 gene transcription and promoter activity through interaction with Rorγ to repress Rorγ transactivation and by interacting with Rev-erb to enhance its inhibition of Rorα activity. Conversely, Npas2 controlled the circadian rhythm of Shp expression by binding rhythmically to the Shp promoter, which was enhanced by nicotinamide adenine dinucleotide, but not nicotinamide adenine dinucleotide phosphate. Phenotypically, Npas2 deficiency induced severe steatosis in Shp-/-mice, which was attributed to the dysregulation of lipoprotein metabolism. The investigators concluded that Shp and Npas2 crosstalk is essential to maintain hepatic lipid homeostasis.

What is the importance of Lee’ study? Firstly, numerous independent in vitro studies have identified a number of interaction partners for SHP, indicating the potential for SHP to regulate a wide array of genes in various biological pathways. Secondly, the existence of an internal circadian clock has long been recognized as natural daily fluctuations have been observed in blood concentrations of glucose, glycolysis, insulin levels and insulin sensitivity.6 Fatty acid and triglyceride levels, as well as lipid metabolising enzymes, display circadian fluctuations.7 Taken these observations together. We can speculate that changes in our lifestyle might affect our circadian rhythms and may also have metabolic and cardiovascular consequences.

The results of the commented study suggest that the metabolic genes analyzed exhibited an oscillatory pattern of expression, consistent with the notion that circadian rhythms and cellular metabolism are intimately linked. Also, as the authors of this study point out. The overall gene expression profile altered by Shp in turn suggesting that SHP mainly serves as a modulator of metabolic homeostasis by interfacing with some pathways to modulate the regulation and function of Npas2.

References
[1.]
Seol W., Choi H.S., Moore D.D..
An orphan nuclear hormone receptor that lacks a DNA bindingdomain and heterodimerizes with other receptors.
Science, 272 (1996), pp. 1336-1339
[2.]
Johansson L., Bavner A., Thomsen J.S., Farnegardh M., Gustafsson J.A., Treuter E..
The orphan nuclear receptor SHP utilizes conserved LXXLL-related motifs for interactions with ligand-activated estrogen receptors.
Mol Cell Biol, 20 (2000), pp. 1124-1133
[3.]
Bookout A.L., Jeong Y., Downes M., Yu R.T., Evans R.M., Mangelsdorf D.J..
Anatomical profiling of nuclear receptor expression reveals a hierarchical transcriptional network.
[4.]
Sanyal S., Kim J.Y., Kim H.J., Takeda J., Lee Y.K., Moore D.D., Choi H.S..
Differential regulation of the orphan nuclear receptor small heterodimer partner (SHP) gene promoter by orphan nuclear receptor ERR isoforms.
J Biol Chem, 277 (2002), pp. 1739-1748
[5.]
Zhang Y., Hagedorn C.H., Wang L..
Role of nuclear receptor SHP in metabolism and cancer.
Biochim Biophys Acta, 1812 (2011), pp. 893-908
[6.]
Aparicio N.J., Puchulu F.E., Gagliardino J.J., et al.
Circadian variation of blood-glucose, plasma-insulin and human growth-hormone levels in response to an oral glucose-load in normal subjects.
Diabetes, 23 (1974), pp. 132-137
[7.]
Schlierf G., Dorow E..
Diurnal patterns of triglycerides, free fatty-acids, blood-sugar, and insulin during carbohydrate-induction in man and their modification by nocturnal suppression of lipolysis.
J Clin Invest, 52 (1973), pp. 732-740
Copyright © 2015. Fundación Clínica Médica Sur, A.C.
Article options
Tools
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos

Quizás le interese:
10.1016/j.aohep.2023.101138
No mostrar más